Sumit Chanda

Sumit K. Chanda is an American research scientist who works on viral and immunological human diseases.[1] He also led the team that built and deployed Metascape for the analysis of omics data.[2] This tool has been cited over 7,600 times since its inception in 2019.[3]

Early life and education

Chanda earned his B.Sc. in biology at Cornell University and his Ph.D. in molecular pharmacology at Stanford University. He completed his postdoctoral training at the Genomics Institute of the Novartis Research Foundation,[4] where he pioneered high-throughput approaches for target identification and validation that enabled preclinical development of novel therapeutics.[5]

Career

In 2014, Chanda, along with Bin Zhou, Yingyao Zhou, Max Chang, Lars Pache and Chris Benner created a free gene annotation and analysis resource called Metascape.[6]

He returned to academic research at Sanford Burnham Prebys Medical Discovery Institute in 2007, where he became director of their Immunity and Pathogenesis program,[7] and joined the Immunology and Microbiology Department at the Scripps Research Institute and Calibr as professor in 2021.[8]

Chanda developed and applied large-scale systems-based approaches to identify host factors critical for viral replication, including influenza, SARS-CoV-2,[9] flaviviruses and HIV-1. His team deployed high-throughput technologies for the discovery of antiviral therapies in response to the COVID-19 pandemic[10] and discovered a novel class of latency reversal agents for an HIV-1 cure (3).

Chanda leads several large, multi-institutional collaborative efforts including the Center for Antiviral Medicines (CAMPP),[11] which is a part of the NIAID Antiviral Drug Discovery (AViDD) network, as well as the Reversing Immune Dysfunction for HIV-1 Eradication Program (RID-HIV), which is a member of the National Institutes of Health's Martin Delaney Collaboratories for HIV Cure Research (MDC) program.[12]

Publications

  • König, R; Zhou, Y; Elleder, D; Diamond, TL; Bonamy, GM; Irelan, JT; Chiang, CY; Tu, BP; De Jesus, PD; Lilley, CE; Seidel, S; Opaluch, AM; Caldwell, JS; Weitzman, MD; Kuhen, KL; Bandyopadhyay, S; Ideker, T; Orth, AP; Miraglia, LJ; Bushman, FD; Young, JA; Chanda, SK (2008). "Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication". Cell. 135: 49–60. doi:10.1016/j.cell.2008.07.032. PMC 2628946. PMID 18854154.
  • König, R; Stertz, S; Zhou, Y; et al. (February 2010). "Human host factors required for influenza virus replication". Nature. 463: 813–7. doi:10.1038/nature08699. PMC 2862546. PMID 20027183.
  • Yoh, SM; Schneider, M; Seifried, J; Soonthornvacharin, S; Akleh, RE; Olivieri, KC; De Jesus, PD; Ruan, C; de Castro, E; Ruiz, PA; Germanaud, D; Portes, V; García-Sastre, A; König, R; Chanda, SK (2015). "PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1". Cell. 161: 1293–1305. doi:10.1016/j.cell.2015.04.050. PMC 4503237. PMID 26046437.
  • Zhou, Y; Zhou, B; Pache, L; Chang, M; Khodabakhshi, AH; Tanaseichuk, O; Benner, C; Chanda, SK (2019). "Metascape provides a biologist-oriented resource for the analysis of systems-level datasets". Nat Commun. 10 (1): 1523.
  • Yuan, S; Yin, X; Meng, X; Chan, JF; Ye, ZW; Riva, L; Pache, L; Chan, CC; Lai, PM; Chan, CC; Poon, VK; Lee, AC; Matsunaga, N; Pu, Y; Yuen, CK; Cao, J; Liang, R; Tang, K; Sheng, L; Du, Y; Xu, W; Lau, CY; Sit, KY; Au, WK; Wang, R; Zhang, YY; Tang, YD; Clausen, TM; Pihl, J; Oh, J; Sze, KH; Zhang, AJ; Chu, H; Kok, KH; Wang, D; Cai, XH; Esko, JD; Hung, IF; Li, RA; Chen, H; Sun, H; Jin, DY; Sun, R; Chanda, SK; Yuen, KY (2021). "Clofazimine broadly inhibits coronaviruses including SARS-CoV-2". Nature. 593: 418–423. doi:10.1038/s41586-021-03431-4. PMID 33727703.
  • Martin-Sancho, L; Lewinski, MK; Pache, L; Stoneham, CA; Yin, X; Becker, ME; Pratt, D; Churas, C; Rosenthal, SB; Liu, S; Weston, S; De Jesus, PD; O'Neill, AM; Gounder, AP; Nguyen, C; Pu, Y; Curry, HM; Oom, AL; Miorin, L; Rodriguez-Frandsen, A; Zheng, F; Wu, C; Xiong, Y; Urbanowski, M; Shaw, ML; Chang, MW; Benner, C; Hope, TJ; Frieman, MB; García-Sastre, A; Ideker, T; Hultquist, JF; Guatelli, J; Chanda, SK (2021). "Functional landscape of SARS-CoV-2 cellular restriction". Mol Cell. 81: 2656–2668.e8. doi:10.1016/j.molcel.2021.04.008. PMC 8043580. PMID 33930332.
  • Yoh, SM; Mamede, JI; Lau, D; Ahn, N; Sánchez-Aparicio, MT; Temple, J; Tuckwell, A; Fuchs, NV; Cianci, GC; Riva, L; Curry, H; Yin, X; Gambut, S; Simons, LM; Hultquist, JF; König, R; Xiong, Y; García-Sastre, A; Böcking, T; Hope, TJ; Chanda, SK (2022). "Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA". Mol Cell. 82: 2871–2884.e6. doi:10.1016/j.molcel.2022.06.010. PMC 9552964. PMID 35809572.

References

  1. ^ Chanda, Sumit (2023-02-21). "How can we prepare for the next pandemic? Sumit Chanda Podcast Highlights" (Interview). Scripps Research. Retrieved 2023-09-22 – via YouTube.
  2. ^ Zhou, Yingyao; Zhou, Bin; Pache, Lars; Chang, Max; Khodabakhshi, Alireza Hadj; Tanaseichuk, Olga; Benner, Christopher; Chanda, Sumit K. (2019-04-03). "Metascape provides a biologist-oriented resource for the analysis of systems-level datasets". Nature Communications. 10 (1): 1523. Bibcode:2019NatCo..10.1523Z. doi:10.1038/s41467-019-09234-6. ISSN 2041-1723. PMC 6447622. PMID 30944313.
  3. ^ "Metascape". metascape.org. Retrieved 2025-02-26.
  4. ^ "Novartis Institutes for BioMedical Research". Novartis. Retrieved 2023-09-22.
  5. ^ "Sumit K. Chanda Inventions, Patents and Patent Applications - Justia Patents Search". Justia. Retrieved 2023-09-22.
  6. ^ Metascape. "The Brief History of Metascape Since 2014 | Metascape Blog". Retrieved 2023-09-28.
  7. ^ Weintraub, Arlene (Apr 20, 2020). "COVID-19: New animal data back up Gilead's remdesivir as other treatment candidates emerge". Fierce Biotech.
  8. ^ "Sumit Chanda". Scripps Research. Retrieved 2023-09-22.
  9. ^ "Meet the authors: Laura Martin-Sancho and Sumit K. Chanda" (PDF). Molecular Cell. June 17, 2021.
  10. ^ "High-throughput screening reveals 21 drugs with activity against COVID-19" (Press release). Retrieved 2023-09-22 – via Drug Target Review.
  11. ^ "NIAID Announces Antiviral Drug Development Awards". National Institute of Allergy and Infectious Diseases (Press release). 2022-05-18. Retrieved 2023-09-22.
  12. ^ Chanda, Sumit. "Sumit Chanda - From HIV to Covid-19 (EP.01)". Model Medicines (Interview). Retrieved 2023-09-22.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.